Skip to main content

Find Clinical Trials

Home
Conditions
Spondylarthritis

Clinical trial condition

Spondylarthritis

Explore clinical trials studying Spondylarthritis. Study availability and eligibility vary by location and protocol.

822 public trials 127 recruiting studies

Refine in advanced search Browse all conditions

Spondylarthritis trial results

Completed

Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis

NCT01892436

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations: Novartis Investigative Site Anniston, Alabama, United States

Novartis Investigative Site Mesa, Arizona, United States

Novartis Investigative Site Paradise Valley, Arizona, United States

Novartis Investigative Site Upland, California, United States

View all 94 locations

View Trial Details

Completed

BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)

NCT02047110

Conditions: Ankylosing Spondylitis (AS), Ankylosis, Arthritis, +9 more
Locations: Not specified

View Trial Details

Completed

BI 655066/ABBV-066/Risankizumab Compared to Placebo in Patients With Active Psoriatic Arthritis

NCT02719171

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +10 more
Locations: Not specified

View Trial Details

Completed

A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (NCT02719171)

NCT02986373

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

Disparity Between Ultrasound- and Clinical Findings in Psoriatic Arthritis in Remission

NCT03396679

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations: CHU Lapeyronie Montpellier, France

View Trial Details

Completed

The Effects of Nanocurcumin on Treg Cells and Th17 Cells Responses in Ankylosing Spondylitis Patients

NCT03140657

Conditions: Ankylosing Spondylitis, Ankylosis, Arthritis, +9 more
Locations: Connective Tissue Diseases Research Center Tabriz, Iran

View Trial Details

Completed

CD73+ Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis

NCT03953378

Conditions: Arthritis, Arthritis, Psoriatic, Arthritis, Rheumatoid, +17 more
Locations: Service de Rhumatologie, Centre Hospitalier Lyon-Sud (HCL) Pierre-Bénite, France

View Trial Details

Completed

24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis

NCT01989468

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations: Novartis Investigative Site Aventura, Florida, United States

Novartis Investigative Site Palm Harbor, Florida, United States

Novartis Investigative Site Sarasota, Florida, United States

Novartis Investigative Site Indianapolis, Indiana, United States

View all 77 locations

View Trial Details

Completed

16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis

NCT02159053

Conditions: Ankylosis, Arthritis, Axial Spondyloarthritis, +8 more
Locations: Novartis Investigative Site Anniston, Alabama, United States

Novartis Investigative Site Upland, California, United States

Novartis Investigative Site Aventura, Florida, United States

Novartis Investigative Site Peoria, Illinois, United States

View all 90 locations

View Trial Details

Completed

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

NCT01329380

Conditions: Ankylosing Spondylitis, Ankylosis, Arthritis, +9 more
Locations: Nagoya City University Hospital Nagoya, Aichi-ken, Japan

Kurume University Hospital Kurume-shi, Fukuoka, Japan

Gunma University Hospital Maebashi, Gunma, Japan

Hyogo College of Medicine Hosp Nishinomiya, Hyōgo, Japan

View all 194 locations

View Trial Details